As of 2025-07-11, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (47.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.39 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -3484.3%.
The range of the Relative Valuation is (39.67) - (47.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 30.3x | 27.2x |
| Forward P/E multiples | 25.3x - 42.7x | 32.9x |
| Fair Price | (39.67) - (47.40) | (47.04) |
| Upside | -2953.9% - -3510.2% | -3484.3% |
| Date | P/E |
| 2025-07-09 | -0.91 |
| 2025-07-08 | -0.86 |
| 2025-07-07 | -0.85 |
| 2025-07-03 | -0.85 |
| 2025-07-02 | -1.37 |
| 2025-07-01 | -1.30 |
| 2025-06-30 | -1.30 |
| 2025-06-27 | -1.35 |
| 2025-06-26 | -1.44 |
| 2025-06-25 | -1.41 |
| 2025-06-24 | -1.32 |
| 2025-06-23 | -1.23 |
| 2025-06-20 | -1.25 |
| 2025-06-18 | -1.25 |
| 2025-06-17 | -1.21 |
| 2025-06-16 | -1.28 |
| 2025-06-13 | -1.28 |
| 2025-06-12 | -1.33 |
| 2025-06-11 | -1.35 |
| 2025-06-10 | -1.44 |
| 2025-06-09 | -1.42 |
| 2025-06-06 | -1.45 |
| 2025-06-05 | -1.35 |
| 2025-06-04 | -1.39 |
| 2025-06-03 | -1.35 |
| 2025-06-02 | -1.34 |
| 2025-05-30 | -1.28 |
| 2025-05-29 | -1.36 |
| 2025-05-28 | -1.28 |
| 2025-05-27 | -1.28 |
| 2025-05-23 | -1.26 |
| 2025-05-22 | -1.29 |
| 2025-05-21 | -1.26 |
| 2025-05-20 | -1.36 |
| 2025-05-19 | -1.32 |
| 2025-05-16 | -1.31 |
| 2025-05-15 | -1.25 |
| 2025-05-14 | -1.20 |
| 2025-05-13 | -1.23 |
| 2025-05-12 | -1.24 |
| 2025-05-09 | -1.15 |
| 2025-05-08 | -1.16 |
| 2025-05-07 | -1.12 |
| 2025-05-06 | -1.09 |
| 2025-05-05 | -1.19 |
| 2025-05-02 | -1.23 |
| 2025-05-01 | -1.21 |
| 2025-04-30 | -1.24 |
| 2025-04-29 | -1.22 |
| 2025-04-28 | -1.21 |